Inventor
HILGARD PETER
DE17 patents
⚠️ This page may combine multiple inventors who share the name “HILGARD PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTA MEDICA AG
9 patentsUS5663145ASep 2, 1997
Products for administering an initial high dose of Cetrorelix and producing a combination package for use when treating diseases
ASTA MEDICA AG32 citations92
US6172050B1Jan 9, 2001
Phospholipid derivatives
ASTA MEDICA AG17 citations91
US5773032AJun 30, 1998
Long-acting injection suspensions and a process for their preparation
ASTA MEDICA AG45 citations90
US6093704AJul 25, 2000
Use of dopamine receptor antagonists in palliative tumor therapy
ASTA MEDICA AG13 citations82
US5219866AJun 15, 1993
Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphate and a process for its preparation
ASTA MEDICA AG10 citations72
US6479472B1Nov 12, 2002
Methods of using therapeutic phospholipid derivatives
ASTA MEDICA AG2 citations61
US5958906ASep 28, 1999
Phospholipid derivatives containing higher elements of the fifth main group
ASTA MEDICA AG1 citations51
US5637577AJun 10, 1997
Phospholipid derivatives containing higher elements of the fifth group
ASTA MEDICA AG1 citations51
US5449798ASep 12, 1995
Phospholipid derivatives containing higher elements of the fifth group
ASTA MEDICA AG1 citations51
ASTA PHARMA AG
3 patentsUS5023335AJun 11, 1991
1,2-bis (aminomethyl) cyclobutane-platinum complexes
ASTA PHARMA AG32 citations89
US5238955AAug 24, 1993
Ethylene-substituted phenylalkylethylenediamine-platinum (II or IV) derivatives and phenylalkylethylenediamines
ASTA PHARMA AG8 citations70
US5194644AMar 16, 1993
Ethylene-substituted phenylalkylethylene-diamine-platinum (ii or iv) derivatives and phenylalkylethylenediamines
ASTA PHARMA AG9 citations70
ZENTARIS AG
3 patentsUS6696428B2Feb 24, 2004
Use of dopamine receptor antagonists in palliative tumor therapy
ZENTARIS AG9 citations73
US6544551B1Apr 8, 2003
Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis
ZENTARIS AG7 citations71
US6576624B1Jun 10, 2003
Use of dopamine receptor antagonists in palliative tumor therapy
ZENTARIS AG0 citations52